These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19737143)

  • 1. Prolonging microtubule dysruption enhances the immunogenicity of chronic lymphocytic leukaemia cells.
    Shaha SP; Tomic J; Shi Y; Pham T; Mero P; White D; He L; Baryza JL; Wender PA; Booth JW; Spaner DE
    Clin Exp Immunol; 2009 Nov; 158(2):186-98. PubMed ID: 19737143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of serum and antioxidants on the immunogenicity of protein kinase C-activated chronic lymphocytic leukemia cells.
    Hammond C; Shi Y; Mena J; Tomic J; Cervi D; He L; Millar AE; Debenedette M; Schuh AC; Baryza JL; Wender PA; Radvanyi L; Spaner DE
    J Immunother; 2005; 28(1):28-39. PubMed ID: 15614042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukaemia.
    Kitada S; Zapata JM; Andreeff M; Reed JC
    Br J Haematol; 1999 Sep; 106(4):995-1004. PubMed ID: 10520003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells.
    Decker T; Schneller F; Sparwasser T; Tretter T; Lipford GB; Wagner H; Peschel C
    Blood; 2000 Feb; 95(3):999-1006. PubMed ID: 10648415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory effects of Toll-like receptor-7 activation on chronic lymphocytic leukemia cells.
    Spaner DE; Shi Y; White D; Mena J; Hammond C; Tomic J; He L; Tomai MA; Miller RL; Booth J; Radvanyi L
    Leukemia; 2006 Feb; 20(2):286-95. PubMed ID: 16341037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vincristine activates c-Jun N-terminal kinase in chronic lymphocytic leukaemia in vivo.
    Bates DJ; Lewis LD; Eastman A; Danilov AV
    Br J Clin Pharmacol; 2015 Sep; 80(3):493-501. PubMed ID: 25753324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Toll-like receptor 7 and Toll-like receptor 9 signaling stimulators and inhibitors on chronic lymphocytic leukemia cells ex vivo and their interactions with cladribine.
    Wolska A; Cebula-Obrzut B; Smolewski P; Robak T
    Leuk Lymphoma; 2013 Jun; 54(6):1268-78. PubMed ID: 23078646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukaemic cells from chronic lymphocytic leukaemia patients undergo apoptosis following microtubule depolymerization and Lyn inhibition by nocodazole.
    Frezzato F; Trimarco V; Martini V; Gattazzo C; Ave E; Visentin A; Cabrelle A; Olivieri V; Zambello R; Facco M; Zonta F; Cristiani A; Brunati AM; Moro S; Semenzato G; Trentin L
    Br J Haematol; 2014 Jun; 165(5):659-72. PubMed ID: 24606526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bryostatin 1-induced hairy cell features on chronic lymphocytic leukemia cells in vitro.
    al-Katib A; Mohammad RM; Dan M; Hussein ME; Akhtar A; Pettit GR; Sensenbrenner LL
    Exp Hematol; 1993 Jan; 21(1):61-5. PubMed ID: 8093352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of Jurkat T cells to phorbol ester and bryostatin. Development of sublines with distinct functional responses and changes in protein kinase C activity.
    Levine BL; May WS; Tyler PG; Hess AD
    J Immunol; 1991 Nov; 147(10):3474-81. PubMed ID: 1834742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of IL-2R beta-binding cytokines on costimulatory properties of chronic lymphocytic leukaemia cells: implications for immunotherapy.
    Spaner DE; Hammond C; Mena J; Shi Y
    Br J Haematol; 2004 Dec; 127(5):531-42. PubMed ID: 15566356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid induction of apoptosis in chronic lymphocytic leukemia cells by the microtubule disrupting agent BNC105.
    Bates D; Feris EJ; Danilov AV; Eastman A
    Cancer Biol Ther; 2016; 17(3):291-9. PubMed ID: 26891146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cell activation through CD40 and IL4R ligation modulates the response of chronic lymphocytic leukaemia cells to BAFF and APRIL.
    Ferrer G; Bosch R; Hodgson K; Tejero R; Roué G; Colomer D; Montserrat E; Moreno C
    Br J Haematol; 2014 Feb; 164(4):570-8. PubMed ID: 24245956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors.
    Fluckiger AC; Rossi JF; Bussel A; Bryon P; Banchereau J; Defrance T
    Blood; 1992 Dec; 80(12):3173-81. PubMed ID: 1281692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase Cdelta-dependent induction of manganese superoxide dismutase gene expression by microtubule-active anticancer drugs.
    Das KC; Guo XL; White CW
    J Biol Chem; 1998 Dec; 273(51):34639-45. PubMed ID: 9852137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and function of toll like receptors in chronic lymphocytic leukaemia cells.
    Muzio M; Scielzo C; Bertilaccio MT; Frenquelli M; Ghia P; Caligaris-Cappio F
    Br J Haematol; 2009 Feb; 144(4):507-16. PubMed ID: 19036098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of the phosphatidylinositol-3-kinase-Akt signaling pathway enhances the induction of apoptosis by microtubule-destabilizing agents in tumor cells in which the pathway is constitutively activated.
    Fujiwara Y; Hosokawa Y; Watanabe K; Tanimura S; Ozaki K; Kohno M
    Mol Cancer Ther; 2007 Mar; 6(3):1133-42. PubMed ID: 17363506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bryostatin 1 induces differentiation of B-chronic lymphocytic leukemia cells.
    Drexler HG; Gignac SM; Jones RA; Scott CS; Pettit GR; Hoffbrand AV
    Blood; 1989 Oct; 74(5):1747-57. PubMed ID: 2506950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT1 mediates differentiation of chronic lymphocytic leukemia cells in response to Bryostatin 1.
    Battle TE; Frank DA
    Blood; 2003 Oct; 102(8):3016-24. PubMed ID: 12855573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy of tumor necrosis factor with protein kinase C activators on T cell activation.
    Muñoz-Fernández MA; Pimentel-Muiños FX; Alonso MA; Campanero M; Sánchez-Madrid F; Silva A; Alonso JL; Fresno M
    Eur J Immunol; 1990 Mar; 20(3):605-10. PubMed ID: 2318252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.